The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of gemcitabine (G), dasatinib (D), and erlotinib (E) in advanced pancreatic carcinoma (PC).
 
Dana Backlund Cardin
Consulting or Advisory Role - Merrimack
Research Funding - Celgene (Inst); EMD Serono (Inst); Incyte (Inst); Oncolytics (Inst); Roche (Inst); Synta (Inst)
 
Laura Williams Goff
Consulting or Advisory Role - Celgene
Research Funding - Amgen; Astellas Pharma; Onyx; Pfizer; Sun Pharma
 
Emily Chan
Consulting or Advisory Role - Amgen; Bayer; Castle Biosciences; EMD Serono; Lilly; Taiho Pharmaceutical
Speakers' Bureau - EMD Serono
Research Funding - Aduro Biotech; Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Dekkun Corporation; Halozyme; Karyopharm Therapeutics; Merrimack; Millennium; Taiho Pharmaceutical
 
Jennifer Whisenant
No Relationships to Disclose
 
Lori R. Arlinghaus
No Relationships to Disclose
 
Thomas Yankeelov
No Relationships to Disclose
 
Tatsuki Koyama
No Relationships to Disclose
 
Jordan Berlin
Consulting or Advisory Role - Boston Biomedical; Celgene; EMD Serono; Genentech/Roche; Ipsen; Janssen Oncology; Lilly/ImClone; Novartis; Pharmacyclics; Symphony Evolution; Targovax; Threshold Pharmaceuticals; Vertex
Research Funding - Abbvie (Inst); Bayer (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Incyte (Inst); Loxo (Inst); Merrimack (Inst); Novartis (Inst); OncoMed (Inst); Symphony Evolution (Inst); Taiho Pharmaceutical (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Abbvie; Boston Biomedical; Celgene; Genentech/Roche; Janssen Oncology
Other Relationship - Momenta Pharmaceuticals; Symphony Evolution
 
Nipun B. Merchant
No Relationships to Disclose